Ansell 将来の成長

Future 基準チェック /46

Ansell利益と収益がそれぞれ年間22.8%と6.7%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に9.9% 21%なると予測されています。

主要情報

22.8%

収益成長率

21.0%

EPS成長率

Medical Equipment 収益成長	16.2%
収益成長率	6.7%
将来の株主資本利益率	9.9%
アナリストカバレッジ	Good
最終更新日	01 Nov 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

CHIA:ANN - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2027	2,080	212	236	287	11
6/30/2026	2,007	189	235	285	11
6/30/2025	1,928	134	146	213	11
6/30/2024	1,619	77	210	272	N/A
3/31/2024	1,612	90	188	256	N/A
12/31/2023	1,605	104	167	239	N/A
9/30/2023	1,630	126	140	210	N/A
6/30/2023	1,655	148	113	181	N/A
3/31/2023	1,717	147	145	213	N/A
12/31/2022	1,778	145	178	245	N/A
9/30/2022	1,865	152	166	234	N/A
6/30/2022	1,952	159	155	222	N/A
3/31/2022	2,025	188	106	176	N/A
12/31/2021	2,098	218	58	130	N/A
9/30/2021	2,063	232	74	152	N/A
6/30/2021	2,027	247	90	173	N/A
3/31/2021	1,913	222	142	222	N/A
12/31/2020	1,798	197	194	270	N/A
9/30/2020	1,706	177	210	279	N/A
6/30/2020	1,614	157	226	287	N/A
3/31/2020	1,570	147	190	246	N/A
12/31/2019	1,527	138	154	204	N/A
9/30/2019	1,513	125	149	197	N/A
6/30/2019	1,499	112	145	189	N/A
3/31/2019	1,496	112	136	181	N/A
12/31/2018	1,493	112	127	172	N/A
9/30/2018	1,491	125	118	163	N/A
6/30/2018	1,490	139	108	154	N/A
3/31/2018	1,461	135	N/A	172	N/A
12/31/2017	1,433	132	N/A	190	N/A
9/30/2017	1,404	125	N/A	203	N/A
6/30/2017	1,375	119	N/A	216	N/A
12/31/2016	1,232	121	N/A	231	N/A
9/30/2016	1,292	129	N/A	232	N/A
6/30/2016	1,353	137	N/A	232	N/A
3/31/2016	1,578	164	N/A	212	N/A
12/31/2015	1,583	169	N/A	191	N/A
9/30/2015	1,614	178	N/A	195	N/A
6/30/2015	1,645	188	N/A	200	N/A
3/31/2015	1,690	126	N/A	231	N/A
12/31/2014	1,734	64	N/A	262	N/A
9/30/2014	1,662	53	N/A	242	N/A
6/30/2014	1,590	42	N/A	221	N/A
3/31/2014	1,507	95	N/A	179	N/A
12/31/2013	1,425	148	N/A	137	N/A

アナリストによる今後の成長予測

収入対貯蓄率: ANNの予測収益成長率 (年間22.8% ) は貯蓄率 ( 2.6% ) を上回っています。

収益対市場: ANNの収益 ( 22.8% ) はAustralian市場 ( 12.4% ) よりも速いペースで成長すると予測されています。

高成長収益: ANNの収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: ANNの収益 ( 6.7% ) Australian市場 ( 5.7% ) よりも速いペースで成長すると予測されています。

高い収益成長: ANNの収益 ( 6.7% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: ANNの自己資本利益率は、3年後には低くなると予測されています ( 9.9 %)。

Ansell 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Ansell Limited Provides Earnings Guidance for the Year 2024

Ansell Limited Provides Earnings Guidance for the Full Year Ended 30 June 2023 and Fiscal Year 2024

Ansell Limited Revises Earnings Guidance for the Fiscal Year 2022

Ansell Limited Provides Earnings Guidance for the Fiscal Year 2022

Ansell Limited Revises Financial Guidance for the Fiscal Year 2021

Recent updates

Ansell Limited Announces Zubair Javeed Intention to Resign as Chief Financial Officer

Final dividend of US$0.22 announced

Ansell Limited Announces Final Dividend for the Year Ended June 30, 2024 , Payable on September 12, 2024

New minor risk - Profit margin trend

Full year 2024 earnings released: EPS: US$0.59 (vs US$1.17 in FY 2023)

Ansell Limited (ASX:ANN) completed the acquisition of Personal Protective Equipment business of Kimberly-Clark Corporation (NYSE:KMB).

Ansell Limited to Report Fiscal Year 2025 Results on Aug 26, 2025

Ansell Limited has filed a Follow-on Equity Offering in the amount of AUD 400.000001 million.

Ansell Limited has filed a Follow-on Equity Offering in the amount of AUD 400.000001 million.

First half dividend of US$0.17 announced

First half 2024 earnings released: EPS: US$0.15 (vs US$0.51 in 1H 2023)

Ansell Limited Declares Dividend for the Six Months Ended December 31, 2023, Payable on March 14, 2024

Ansell Limited Provides Earnings Guidance for the Year 2024

Ansell Limited Declares Final Dividend for Year Ended 30 June 2023, Payable on 7 September 2023

Full year 2023 earnings released: EPS: US$1.18 (vs US$1.25 in FY 2022)

Investor sentiment deteriorates as stock falls 16%

Ansell Limited Provides Earnings Guidance for the Full Year Ended 30 June 2023 and Fiscal Year 2024

Ansell Limited to Report First Half, 2024 Results on Feb 20, 2024

Ansell Limited to Report First Half, 2024 Results on Feb 20, 2024

Now 21% undervalued after recent price drop

Ansell Limited Announces Board Changes, Effective on 24 October 2023

First half 2023 earnings released: EPS: US$0.51 (vs US$0.61 in 1H 2022)

Now 24% undervalued after recent price drop

Ansell Limited Announces Dividend for the Six Months Ended December 31, 2022, Payable on March 9, 2023

Ansell Limited Announces Appointment of Debra Goodin as an Independent Nonexecutive Director

Non-Executive Director recently bought AU$130k worth of stock

Ansell Limited to Report First Half, 2023 Results on Feb 14, 2023

Full year 2022 earnings released: EPS: US$1.25 (vs US$1.92 in FY 2021)

Ansell Limited, Annual General Meeting, Oct 26, 2023

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Ansell Limited Announces Dividend for the Period of Six Months Ended December 31, 2021, Payable on March 09, 2022

Investor sentiment deteriorated over the past week

Ansell Limited Revises Earnings Guidance for the Fiscal Year 2022

High number of new directors

Ansell Limited Provides Earnings Guidance for the Fiscal Year 2022

Full year 2021 earnings released: EPS US$1.92 (vs US$1.22 in FY 2020)

New 90-day high: AU$39.25

First half 2021 earnings released: EPS US$0.83 (vs US$0.50 in 1H 2020)

Revenue misses expectations

Ansell Limited Revises Financial Guidance for the Fiscal Year 2021

Ansell Limited (ASX:ANN) acquired life science business from Primus Gloves Private Limited and SANREA Healthcare Products Pvt Limited.

Independent Non-Executive Director recently sold AU$260k worth of stock

New 90-day low: AU$35.58

MD, CEO & Executive Director recently sold AU$3.2m worth of stock

New 90-day high: AU$42.03

New 90-day high: AU$41.05

Independent Non-Executive Director recently bought AU$55k worth of stock

Independent Non-Executive Director recently bought AU$55k worth of stock

Full year earnings released - EPS AU$1.22

Ansell Limited to Report Fiscal Year 2021 Results on Aug 24, 2021

New 90-day high - AU$40.57

New 90-day high - AU$39.20

Ansell Limited (ASX:ANN) completed the acquisition 50% stake in CAREPLUS (M) SDN. BHD from Careplus Group Berhad (KLSE:CAREPLS).

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘